Insider · CIK 0001296996
Andrea Corcoran
Files at AVIR (Atea Pharmaceuticals, Inc.). First filing -, latest -.
Andrea Corcoran files SEC Form 4 as officer at AVIR (Atea Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Andrea Corcoran has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | AVIR Atea Pharmaceuticals, Inc. | MOption exercise Common Stock | +60,000 | $1.24 | $74k | 823,576 | Mar 13, 2026 |
| Mar 11, 2026 | AVIR Atea Pharmaceuticals, Inc. | MOption exercise Stock Option (Right to Buy)derivative | +60,000 | $0.00 | $0 | 0 | Mar 13, 2026 |
| Jan 31, 2026 | AVIR Atea Pharmaceuticals, Inc. | MOption exercise Common Stock | +54,866 | - | - | 779,680 | Feb 3, 2026 |
| Jan 31, 2026 | AVIR Atea Pharmaceuticals, Inc. | FTax withholding Common Stock | -16,104 | $4.24 | $68k | 763,576 | Feb 3, 2026 |
| Jan 31, 2026 | AVIR Atea Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -44,366 | $0.00 | $0 | 0 | Feb 3, 2026 |
| Jan 31, 2026 | AVIR Atea Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -10,500 | $0.00 | $0 | 0 | Feb 3, 2026 |
| Jan 31, 2026 | AVIR Atea Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +180,000 | $0.00 | $0 | 180,000 | Feb 3, 2026 |
| Jan 31, 2025 | AVIR Atea Pharmaceuticals, Inc. | MOption exercise Common Stock | +44,367 | - | - | 722,909 | Feb 4, 2025 |
| Jan 31, 2025 | AVIR Atea Pharmaceuticals, Inc. | AGrant or award Common Stock | +10,500 | - | - | 733,409 | Feb 4, 2025 |
| Jan 31, 2025 | AVIR Atea Pharmaceuticals, Inc. | FTax withholding Common Stock | -16,102 | $3.06 | $49k | 717,307 | Feb 4, 2025 |
| Jan 31, 2025 | AVIR Atea Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -44,367 | $0.00 | $0 | 44,366 | Feb 4, 2025 |
| Jan 31, 2025 | AVIR Atea Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +10,500 | $0.00 | $0 | 10,500 | Feb 4, 2025 |
| Jan 31, 2025 | AVIR Atea Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +200,000 | $0.00 | $0 | 200,000 | Feb 4, 2025 |
Questions about Andrea Corcoran
Answered from the filings on this page, as of the latest one.
Is Andrea Corcoran buying or selling?
Andrea Corcoran has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Andrea Corcoran's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Andrea Corcoran has 0.
Where does Andrea Corcoran file Form 4?
Andrea Corcoran has filed Form 4 at AVIR (Atea Pharmaceuticals, Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.